Aura Biosciences Inc (AURA)
NASDAQ:AURA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ -1.29M | $ -1.18M | $ 0.00 |
| Operating Income | $ -112.79M | $ -96.12M | $ -84.99M | $ -60.30M | $ -35.25M |
| EBITDA | $ -111.66M | $ -94.89M | $ -83.70M | $ -59.12M | $ -34.42M |
| Net Income | $ -106.19M | $ -86.92M | $ -76.41M | $ -58.76M | $ -35.25M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 144.24M | $ 151.09M | $ 226.15M | $ 188.81M | $ 149.06M |
| Total Assets | $ 169.43M | $ 182.50M | $ 255.07M | $ 223.94M | $ 160.03M |
| Total Debt | $ 17.38M | $ 18.77M | $ 19.56M | $ 20.86M | $ 975.00K |
| Net Debt | $ -42.14M | $ -12.92M | $ -21.51M | $ -100.72M | $ -148.09M |
| Total Liabilities | $ 32.52M | $ 30.53M | $ 29.23M | $ 28.35M | $ 7.71M |
| Stockholders' Equity | $ 136.91M | $ 151.97M | $ 225.85M | $ 195.58M | $ 152.31M |
| Cash Flow | |||||
| Free Cash Flow | $ -85.19M | $ -81.06M | $ -64.56M | $ -55.70M | $ -34.53M |
| Operating Cash Flow | $ -84.74M | $ -79.81M | $ -63.85M | $ -54.60M | $ -32.41M |
| Investing Cash Flow | $ 35.59M | $ 68.82M | $ -113.96M | $ -67.87M | $ -2.13M |
| Financing Cash Flow | $ 77.16M | $ 1.59M | $ 97.29M | $ 95.63M | $ 166.26M |